People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioAge Labs, Inc. | — | Biotechnology | Series D+ | $194.4M | $2.4B | 2024 |
Rehka Hemrajani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rehka Hemrajani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Enright | 1 | 10 |
| Vijay Pande | 1 | 9 |
| James Healy | 1 | 8 |
| Dov Goldstein | 1 | 6 |
| Jason Coloma | 1 | 3 |
| Eric Morgen | 1 | 1 |
| Kristen Fortney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.